Skip to main content

enGene Holdings Inc.

For the period ended Oct 31, 2025. Filed Dec 22, 2025.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Dec 22, 2025

ENGN$1.67-5.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets as of October 31, 2025 and

October 31, 2025October 31, 2024
Assets
Current assets:
Cash and cash equivalents$50,152$173,004
Marketable securities - short term143,58465,328
Restricted investments7972
Investment tax credits receivable927332
Prepaid and other current assets6,6498,626
Total current assets201,391247,362
Marketable securities - long term8,52259,527
Property and equipment, net2,4771,169
Operating lease right of use asset7,7161,741
Other assets1,3621,374
Total assets$221,468$311,173
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable$6,688$1,411
Accrued expenses and other current liabilities15,27512,128
Operating lease liabilities, current2,014423
Current portion of note payable8,002699
Total current liabilities31,97914,661
Note payable, net of current portion15,32422,473
Operating lease liabilities, net of current portion6,4551,427
Total liabilities53,75838,561
Shareholders’ equity:
Common shares, no par value; unlimited shares authorized, 52,018,658 and 50,976,676 shares issued and outstanding as of October 31, 2025 and October 31, 2024, respectively.513,281509,811
Additional paid-in capital27,34918,950
Accumulated other comprehensive loss(888)(1,419)
Accumulated deficit(372,032)(254,730)
Total shareholders’ equity167,710272,612
Total liabilities and shareholders’ equity$221,468$311,173
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.